How RareJourney aligns with Australian and international privacy regulations.
Privacy Act 1988 (Cth)
RareJourney's privacy practices are designed to comply with all 13 Australian Privacy Principles, including:
Privacy Act 1988 (Cth), Part IIIC
RareJourney maintains a documented incident response procedure aligned with OAIC requirements. In the event of an eligible data breach, we will notify affected individuals and the OAIC as required by law. See Incident Response.
Therapeutic Goods Act 1989
RareJourney does not make diagnostic or therapeutic claims and is not classified as a medical device under Australian law. The app is a health information management and support tool, not a diagnostic or treatment platform. All AI companion responses include disclaimers directing users to consult healthcare professionals.
Apple App Store & Google Play Store requirements
RareJourney's App Store privacy labels accurately reflect our data collection and use practices. Privacy nutrition labels are kept up to date with any changes to data handling practices.
Automated decision-making transparency requirements
POLA 2024 introduces new obligations for automated decision-making (ADM) systems. While RareJourney's AI companion does not make automated decisions that have legal or significant effects on individuals, we are implementing additional transparency measures:
Implementation target: Q3 2026 (ahead of December 2026 deadline)
General Data Protection Regulation (EU)
RareJourney's architecture is designed to support GDPR compliance when we expand to European markets:
Health Insurance Portability and Accountability Act (US)
Our infrastructure partners support Business Associate Agreements (BAAs) and our architecture is designed to support HIPAA compliance if we expand to US healthcare partnerships:
As RareJourney grows and partners with healthcare institutions, we plan to pursue:
Regulatory compliance isn't a checkbox — it's an ongoing commitment to protecting your privacy and earning your trust. We: